Small Caps
Ophir Energy extends deadline for Medco takeover offer
Ophir Energy has extended the deadline for Indonesian oil and gas producer Medco Energi Internasional to make a firm takeover offer or walk away from a deal, the company reported on Monday.
Eurasia Mining's Ural operations to commence with specially formed contractor
Eurasia Mining confirmed on Monday that its subsidiary Kosvinsky Kamen has agreed with contractor Uralmetmash to carry out mining at the West Kytlim mine in Russia's Ural mountains.
Jangada's 117% jump in JORC resource is 'significant step forward'
Jangada Mines climbed on Monday after announcing the doubling of its resource at the Pedra Branca platinum group metals project in Brazil.
Nucleus Financial pleased with asset performance at year-end
Independent wrap platform provider Nucleus Financial Group updated the market on its assets under administration for the 12-month period to 31 December on Monday, reporting that they stood at £13. 9bn as at period end, up 2. 3% over the year.
Kromek wins new $58m medical imaging contract
Detection technology provider Kromek has been awarded a new contract by an existing OEM customer, it announced on Monday, expected to be worth a minimum of $58. 1m over a seven-year period.
Losses widen at Sensyne Health as it announces new agreements
Clinical artificial intelligence (AI) technology company Sensyne Health announced its interim results for the six months ended 31 October on Monday, reporting cash and cash equivalents of £57. 7m at period-end.
LXI acquires four new assets with funds from new Scottish Widows loan facility
Real estate investment trust LXI has utilised its new 15-year Scottish Widows loan facility to fund the acquisition of four new assets.
Horizon Discovery agrees gene editing partnership with Rutgers
Horizon Discovery Group has entered into an exclusive strategic partnership with Rutgers, The State University of New Jersey, to develop and commercialise a novel gene editing technology, known as base editing.
Shore Capital in talks to buy rival Stockdale Securities
City stockbroker Shore Capital confirmed on Monday that it is in talks about a potential acquisition of rival Stockdale Securities.
Reabold flows upward as California well test beats expectations
Reabold Resources climbed on Monday after a successful test at its VG-4 well at the West Brentwood field in California exceeded pre-drill expectations.
Leeds Group's profit increases amid challenging conditions
Fabrics wholesaler Leeds Group on Monday reported growth in profit before tax despite a reduction in revenue for the first half of its fiscal year.
SDX Energy plans TSXV delisting
Oil and gas exploration outfit SDX Energy intends to delist from the Toronto Stock Exchange ahead of a move of its corporate residence to the UK from Canada.
TT Electronics to optimise manufacturing following Stadium Group integration
TT Electronics on Monday laid out new plans to improve manufacturing following the integration of its Stadium Group PLC acquisition.
Maintel expects earnings at top end of guidance
Communication services Maintel traded "comfortably" in line with revised market expectations in its recently wrapped up trading year.
PCI-PAL jumps after US contracts bolster recurring revenues
PCI-PAL gained on Monday after reporting that recurring contracts won in the first six months of its financial year more than doubled that of the entire prior year.
Rockfire raises £500,000 to fund Marengo and Double Event projects
AIM-quoted copper and gold exploration company Rockfire Resources has raised £500,000 by way of a placing of 58. 82m new ordinary shares at a price of 0. 85p each.
Abcam accquires Californian antibodies manufacturer
Antibody supplier Abcam has acquired Californian monoclonal antibodies manufacturer Calico Biolabs for an undisclosed amount.
Stocks Spirits backer orders another round of changes
Almost three years after ousting one Stock Spirits chief executive, the distillery company's top shareholder is again looking to shake and stir things up.
Destiny Pharma sees success in latest trial of XF-73 nasal gel
Clinical stage biotechnology company Destiny Pharma announced positive data and the non-irritant classification for its XF-73 nasal gel on Monday.
Flybe board puts support behind chair in Hosking dispute
Flybe shares took off in early trade on Monday after the group threw its weight behind chairman Simon Laffin just days after a major shareholder called for his resignation.